Archer Investment Corporation’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$957K Buy
7,578
+300
+4% +$39.5K 0.19% 103
2026
Q1
$1.01M Buy
7,278
+1
+0% +$140 0.22% 90
2025
Q4
$893K Hold
7,277
0.2% 102
2025
Q3
$808K Hold
7,277
0.18% 101
2025
Q2
$807K Buy
7,277
+87
+1% +$9.26K 0.19% 105
2025
Q1
$806K Hold
7,190
0.21% 93
2024
Q4
$664K Hold
7,190
0.18% 107
2024
Q3
$603K Buy
7,190
+1,454
+25% +$111K 0.16% 118
2024
Q2
$394K Buy
5,736
+5,600
+4,118% +$374K 0.11% 161
2024
Q1
$9.96K Hold
136
﹤0.01% 654
2023
Q4
$11K Hold
136
﹤0.01% 634
2023
Q3
$10.2K Sell
136
-31
-19% -$2.38K ﹤0.01% 618
2023
Q2
$12.9K Hold
167
﹤0.01% 569
2023
Q1
$13.9K Hold
167
0.01% 530
2022
Q4
$14.3K Buy
167
+75
+82% +$5.94K 0.01% 506
2022
Q3
$5.67K Hold
92
﹤0.01% 583
2022
Q2
$5.69K Hold
92
﹤0.01% 595
2022
Q1
$5.69K Hold
92
﹤0.01% 600
2021
Q4
$6.68K Buy
92
+36
+64% +$2.48K ﹤0.01% 580
2021
Q3
$3.91K Hold
56
﹤0.01% 606
2021
Q2
$3.86K Hold
56
﹤0.01% 507
2021
Q1
$3.62K Sell
56
-900
-94% -$58K ﹤0.01% 633
2020
Q4
$55.7K Sell
956
-66
-6% -$3.98K 0.03% 271
2020
Q3
$64.6K Buy
1,022
+1
+0.1% +$69 0.03% 232
2020
Q2
$78.6K Buy
1,021
+9
+0.9% +$690 0.04% 216
2020
Q1
$76K Buy
1,012
+500
+98% +$34.5K 0.05% 207
2019
Q4
$33K Hold
512
0.02% 320
2019
Q3
$32K Hold
512
0.02% 263
2019
Q2
$35K Hold
512
0.02% 257
2019
Q1
$33K Buy
512
+56
+12% +$3.72K 0.02% 262
2018
Q4
$29K Buy
+456
New +$31.9K 0.03% 254

Other funds holding GILD

Archer Investment Corporation's GILD Position: Q2 2026 in Review

Archer Investment Corporation increased its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, buying an estimated $39.5K and bringing the position to 7,578 shares worth $957K. The position accounts for 0.19% of the portfolio, ranked #103.

Archer Investment Corporation first reported a position in GILD in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.01M in Q1 2026. 1,205 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Archer Investment Corporation held 7,578 shares of Gilead Sciences worth $957K as of Q2 2026.
  • Archer Investment Corporation bought 300 Gilead Sciences shares in Q2 2026, an estimated $39.5K.
  • Gilead Sciences made up 0.19% of Archer Investment Corporation's portfolio in Q2 2026, its #103 holding.
  • Archer Investment Corporation first reported a position in Gilead Sciences in Q4 2018 and has held it in 31 quarters since.
  • Archer Investment Corporation's Gilead Sciences position peaked at $1.01M in Q1 2026.
  • 1,205 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Archer Investment Corporation's 13F filing for Q2 2026, filed 3 Aug 2026.